TRACON Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the […]
Catalyst Pharmaceuticals to Hold Second Quarter 2020 Financial Results and Corporate Update Conference Call and Webcast on Tuesday, August 11th, 2020
CORAL GABLES, Fla., Aug. 03, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
Celldex to Report Second Quarter 2020 Financial Results and Host Corporate Update Call
HAMPTON, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) will report second quarter 2020 financial results on […]
Intellia Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing […]
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
— Appointed David Meeker, M.D., as President and Chief Executive Officer –— FDA granted rare pediatric disease designations for setmelanotide […]
Neos Therapeutics to Host Second Quarter 2020 Financial and Operating Results Conference Call on August 10th, 2020
DALLAS and FORT WORTH, Texas, Aug. 03, 2020 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company […]
Akouos to Present at BTIG Virtual Biotechnology Conference
BOSTON, Aug. 03, 2020 (GLOBE NEWSWIRE) — Akouos, Inc. (“Akouos”) (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing […]
Cerence Introduces Cerence Reader, a “Breathtaking,” Human-Like Virtual Newscaster for the Car
BURLINGTON, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced […]
Gritstone Oncology to Present at Two Upcoming Investor Conferences in August
EMERYVILLE, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation […]
Cabaletta Bio to Present at Multiple August Investor Conferences
PHILADELPHIA, Aug. 03, 2020 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery […]
